amifostine anhydrous has been researched along with ephedrine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Carrithers, SL; Lefer, AM; Nuss, C; Owen, CS; Parkinson, SJ; Pooler, PM; Ryan, SV; Skurk, C; Waldman, SA | 1 |
1 review(s) available for amifostine anhydrous and ephedrine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for amifostine anhydrous and ephedrine
Article | Year |
---|---|
Hypotensive mechanisms of amifostine.
Topics: Adrenergic Agents; Amifostine; Animals; Aorta, Thoracic; Arginine; Blood Pressure; Calcium; Cyclic AMP; Cyclic GMP; Ephedrine; Hypotension; In Vitro Techniques; Ligands; Male; Mercaptoethylamines; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Radiation-Protective Agents; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha | 1996 |